DIM
IONS icon

DC Investments Management’s Ionis Pharmaceuticals IONS Stock Holding History

DC Investments Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,380
Closed -$317K – 182
2020
Q2 		$317K Buy
+5,380
New +$299K 0.12% 176

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

DC Investments Management's IONS Position: Q3 2020 in Review

DC Investments Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2020, closing a stake of 5,380 shares — an estimated $317K sold.

DC Investments Management first reported a position in IONS in Q2 2020 and held it in 1 quarter. The position peaked at $317K in Q2 2020. 367 funds tracked by Wall St. Rank hold IONS as of Q3 2020.

  • DC Investments Management reported no remaining Ionis Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • DC Investments Management sold 5,380 Ionis Pharmaceuticals shares in Q3 2020, an estimated $317K.
  • DC Investments Management first reported a position in Ionis Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • DC Investments Management's Ionis Pharmaceuticals position peaked at $317K in Q2 2020.
  • 367 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.